|Current Hot Topics|
CMS Informational Bulletin on Collaborative Practice Agreements
This guidance addresses flexibilities that states may have to facilitate timely access to specific drugs by expanding the scope of practice and services that can be provided by pharmacists, including dispensing drugs based on their own independently initiated prescriptions, collaborative practice agreements (CPA) with other licensed prescribing healthcare providers like physicians, “standing orders” issued by the state, or other predetermined protocols. These practices can facilitate easier access to medically necessary and time-sensitive drugs for Medicaid beneficiaries.
This letter outlines how pharmacists can fight the opioid epidemic by encouraging people to get rid of unwanted or unused prescription medications.
This page includes a host of resources of naloxone.
Pennsylvania has passed legislation authorizing the use of certain forms of marijuana for the treatment of certain disease states. The PA Dept of Health is charged with developing enabling regulations.
Thomas Jefferson University, Lambert Center for the Study of Medicinal Cannabis and Hemp.
Pennsylvania Department of Health Medical Marijuana Program
Nondiscrimination in Health Programs and Activities
The U.S. Department of Health & Human Services released the Nondiscrimination in Health Programs and Activities Final Rule in May of this year. Most of the provisions of this rule go into effect Monday, July 18, 2016.
Key requirements affecting pharmacies include:
For more information and tips on how to comply, please see this resource from the American Pharmacists Association.
NCPA has put together a resource page that explains more about DIR fees and how independents can cope with this.